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Abstract
We previously described a Multilocus Sequence Typing (MLST) scheme based on eight genes that facilitates population
genetic and evolutionary analysis of P. acnes. While MLST is a portable method for unambiguous typing of bacteria, it is
expensive and labour intensive. Against this background, we now describe a refined version of this scheme based on two
housekeeping (aroE; guaA) and two putative virulence (tly; camp2) genes (MLST4) that correctly predicted the phylogroup
(IA1, IA2, IB, IC, II, III), clonal complex (CC) and sequence type (ST) (novel or described) status for 91% isolates (n = 372) via
cross-referencing of the four gene allelic profiles to the full eight gene versions available in the MLST database (http://
pubmlst.org/pacnes/). Even in the small number of cases where specific STs were not completely resolved, the MLST4
method still correctly determined phylogroup and CC membership. Examination of nucleotide changes within all the MLST
loci provides evidence that point mutations generate new alleles approximately 1.5 times as frequently as recombination;
although the latter still plays an important role in the bacterium’s evolution. The secreted/cell-associated ‘virulence’ factors
tly and camp2 show no clear evidence of episodic or pervasive positive selection and have diversified at a rate similar to
housekeeping loci. The co-evolution of these genes with the core genome might also indicate a role in commensal/normal
existence constraining their diversity and preventing their loss from the P. acnes population. The possibility that members of
the expanded CAMP factor protein family, including camp2, may have been lost from other propionibacteria, but not P.
acnes, would further argue for a possible role in niche/host adaption leading to their retention within the genome. These
evolutionary insights may prove important for discussions surrounding camp2 as an immunotherapy target for acne, and
the effect such treatments may have on commensal lineages.
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Introduction
Propionibacterium acnes is an anaerobic, Gram-positive opportu-
nistic pathogen that forms part of the normal microbiota on
human skin and mucosal surfaces. The traditional view of this
bacterium as a relatively harmless member of the normal human
microbiota is now constantly challenged in the literature, with
increasing descriptions of its role in human infections and clinical
conditions. Although most notably linked to the inflammatory skin
condition acne vulgaris [1], growing evidence now supports an
important role in other human diseases, including infections of
indwelling medical devices [2–4], and potential roles in the
aetiology of sarcoidosis [5,6] and prostate cancer [7,8]. Despite
this, the fact that P. acnes is present in both the normal and disease
states often frustrates attempts to assign a definite role in various
human diseases via fulfilment of Koch’s postulates.
In collaboration with the University of Warwick, UK, we
previously described a Multilocus Sequence Typing (MLST)
scheme and database for P. acnes that utilised seven housekeeping
genes (MLST7; 3135 bp) [9]. The Warwick scheme, which was
established to build upon our earlier epidemiological and
phylogenetic studies of P. acnes, resolves isolates into major
evolutionary clades, designated types IA1, IA2, IB, IC, II and
III, which differ in their association with disease, production of
putative virulence determinants, immunogenic and inflammatory
properties, as well as biochemical, aggregative and morphological
characteristics [7,9–18]. We used this scheme to stratify isolates
into sequence types (STs) within these statistically significant
genetic groupings, thus facilitating studies of their association with
different infections and cell surface antigens [9]. To provide a
deeper level of resolution, primarily for the type IA1 phylogroup,
we recently published an updated and expanded eight gene
version of the scheme based on six housekeeping and two ‘putative
virulence’ genes; the latter encode a proposed secreted haemoly-
sin/cytotoxin (tly) and cell-associated Christie Atkins Munch
Petersen (CAMP) homologue (4253 bp) [17]. The introduction
of virulence genes into MLST schemes is now increasingly
common as these loci are often more diverse and therefore provide
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greater discrimination as a result of positive or diversifying
selection. Application of the scheme to a large collection of
isolates from disparate clinical sources, as well as healthy skin,
identified clonal complexes (CC) and associated lineages with an
apparent heightened capacity to cause infection, and others that
may be associated with a commensal existence and skin health.
This was in keeping with the observations of Lomholt and Kilian
[16].
Compared with gel-based typing schemes, such as pulsed-field
gel electrophoresis or random amplification of polymorphic DNA
(RAPD) methods, MLST is a highly portable technique that
provides unambiguous genotype assignments and also provides
data that is amenable for evolutionary and population genetic
analysis. Furthermore, due to the greater number of informative
nucleotide sites analysed, as well as the buffering effects that
multiple loci provide against the distorting effects of recombina-
tion, MLST provides much deeper and more accurate population
genetic data on P. acnes compared to previously described single
locus phylotyping methods which have solely targeted the tly or
recA gene [11,15,18–22]; this latter locus has been widely applied
in bacterial systematics and has proven valuable for phylogenetic
resolution of closely related taxa that show high 16S rDNA
sequence identity [23]. While the MLST method has become the
gold standard for bacterial typing, it is expensive, as well as labour
intensive and time consuming. This has limited its widespread
uptake by researchers and routine diagnostic laboratories. A
scheme that could provide phylogenetically accurate genotyping
information, but based on a significantly reduced number of loci
would, therefore, be beneficial and attractive. In the first part of
this paper we describe a refined four gene MLST scheme based on
aroE-guaA-tly-camp2 (MLST4) that provides valuable typing data for
researchers, but with a significant reduction in costs, labour and
time. The method should be particularly suitable for the analysis of
large collections of isolates, enabling stratification of strains for
further downstream study. We then develop this MLST theme by
using our current multilocus sequence data to further understand
the role of specific lineages in human health and disease. In the
second part we provide insights into the roles played by mutation
and recombination during clonal diversification and propose a
probable model for CAMP factor homologue evolution in
propionibacteria. These evolutionary-based studies are especially
relevant to ongoing discussions concerning the use of CAMP
factor 2 as a potential therapeutic target.
Results and Discussion
Levels of genetic diversity between MLST loci
The number of loci selected for MLST analysis depends on the
particular epidemiological questions being asked and the mini-
mum resolution necessary to provide the answer; this also has to be
balanced against the time and expense required when characteris-
ing multiple isolates. Against this background, we examined what
impact reducing the eight loci we routinely utilise for MLST would
have on the discriminatory power of our scheme and whether it
would still be possible to accurately determine the phylogroup,
clonal complex (CC) and ST of isolates by cross-referencing a
reduced allelic profile to the full profiles available in the growing P.
acnes MLST database (http://pubmlst.org/pacnes/). If possible,
this would have significant financial and practical implications for
researchers wishing to analyse large numbers of P. acnes isolates.
At the onset of this specific study we had examined a total of 285
isolates by MLST8 resulting in the generation of 91 STs. Against
this large collection of sequence data we determined the most
diverse set of loci within our scheme based on a range of criteria
detailed in Table 1. The number of alleles per locus ranged from
10 (lepA) to 33 (camp2), while the number of polymorphic sites
ranged from 16 (3.54%; lepA) to 79 (9.82%; camp2) and nucleotide
diversity by locus varied from 1.00% (atpD) to 2.60% (camp2). The
discriminatory index (D) was the lowest for atpD (42.3%) and the
highest for camp2 (83.7%). While the tly and camp2 genes had the
highest number of alleles due to greater sequence lengths, the %
polymorphic sites and p values were not significantly different
from the housekeeping loci providing evidence that all the genes
were diversifying at approximately similar rates (Table 1).
Discriminatory power of the MLST4 scheme for
genotyping of P. acnes
On the basis of these initial analyses, five loci were selected for
further investigation; these were aroE, guaA, sodA, tly and camp2
(Figure 1). With the sequence information available from the
previous analysis of 285 isolates [17], we initially investigated a
four locus MLST approach based on a combination of aroE-guaA-
tly-camp2 (MLST4; 2498 bp) for the discrimination of P. acnes
isolates. To prevent confusion, the same ST numbering of unique
genotypes was maintained between schemes. A total of 75 distinct
STs were resolved with an overall D value of 93% (95% CI 91.3–
94.5) (Table 1; Table S1). With the eight gene scheme (MLST8) a
total of 91 STs were resolved with a D value of 94% (95% CI
92.3–95.3) (p,0.001) (Table 1; Table S1). The overall concor-
dance between the two methods as measured by the adjusted
Rand value was 91.8% (95% CI 87–96.7). We also compared
these results with a four locus scheme based on a combination of
guaA-sodA-tly-camp2 (2524 bp). With these loci, only 65 distinct STs
were differentiated with an overall D value of 91% (95% CI 89.3–
93.1). This reduced discriminatory index value was significantly
different from both the MLST4 (p,0.001) and MLST8 schemes
(p,0.001). Rand values between this combination of alleles and
MLST8 were 81.2% (95% CI 73.8–88.7) and between both
MLST4 methods 89.1% (95% CI 83.1–95.1). On this basis, further
analyses were only carried out with the aroE-guaA-tly-camp2
scheme.
We further examined the MLST4 method against the P. acnes
MLST scheme adopted by Lomholt and Kilian [16] at Aarhus
University, Denmark and based on nine housekeeping genes
(MLST9; all different from our scheme). To achieve this, we
examined a subset of 86 P. acnes isolates from our MLST collection
for which Aarhus MLST data was available. These included 72
isolates from the Human Microbiome Project (HMP) and other
sequencing programmes, along with 14 Danish isolates described
in the original Aarhus MLST publication [16]. Results from the
MLST4 and MLST9 methods were similar with both schemes
discriminating a total of 27 STs, with D values of 91% (95% CI
87.5–93.6) and 93% (CI 91.2–95.6%), respectively (p = 0.105).
With the MLST8 method, a total of 32 STs were resolved with a D
value of 93% (CI 91.3–95.9%) (p = 0.058 vs MLST4 and
p = 0.353 vs MLST9). While MLST8 appears to demonstrate
higher levels of resolution overall when compared to the MLST9
method, the two schemes are essentially concordant in respect to
the clustering of isolates into CCs, although some differences in the
resolution of particular lineages within CCs exist [17].
By cross-referencing the allelic profile for each of the 75/91STs
(82%) resolved by MLST4 to the full allelic profiles currently
available within the P. acnes MLST database (http://pubmlst.org/
pacnes/), it was possible to accurately determine the phylogroup
(IA1, IA2, IB, IC, II and III) and CC/singleton identity of the
isolates (Table S1). Even for the 16 STs that could not be fully
resolved using the MLST4 approach, their allelic profile still
accurately predicted phylogroup and CC membership (Table S1).
P. acnes: Human Disease & Evolutionary Insights
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For these STs, the MLST4 method still generated important
phylogenetic data.
Comparison of MLST analysis with 16S rDNA ribotyping
methods
We also compared the discriminatory power of our MLST
methods with the results obtained upon 16S rDNA-based
ribotyping analysis, which has recently been described as a useful
method to distinguish major P. acnes lineages [24]; to do this, we
compared 81 isolates from the HMP. Analysis of this isolate cohort
by MLST8 resolved a total of 35 STs with a D value of 93% (CI
89.5–95.7%), and by MLST4 a total of 32 STs with a D value of
92% (CI 88.6–95.1%) (p = 0.139). In comparison, sequence
analysis of the entire 16S rDNA gene revealed only 10 ribotypes
with a D value of 81% (CI 75.2%–86.1%). As expected, 16S
rDNA-based ribotyping had significantly reduced resolving power
when compared to MLST analysis based on multiple protein-
encoding genes (p,0.001), which generally diverge at a faster rate.
This is illustrated by the overlap of ribotype 1 between strains from
the type IA1 and IB divisions; and ribotype 5 between strains from
the IA1 and IC phylogroups. Furthermore, inter-division (I, II and
III) ribotypes, unlike equivalent recA alleles, only differ by a very
small number of polymorphic sites. The clear differences between
both typing approaches must be balanced, however, against the
practicalities of analysing only one gene (16S rDNA) versus
multiple genes (MLST). The method adopted will therefore
depend on the degree of resolution required for the epidemiolog-
ical issues being addressed.
New aroE amplification and sequencing primers for MLST
Over the course of our previous MLST studies we have
observed that the PCR primers described for aroE, and originally
designed against the then only available whole genome sequence
of P. acnes represented by strain KPA171202 (type IB, ST5, CC5)
[25], can give poor amplification of this gene from type II strains.
Furthermore, we have also found that aroE nucleotide sequences
produced using the reverse sequencing primer often produce
reduced quality reads compared to those obtained with the
forward sequencing primer. To investigate these issues further, we
aligned complete aroE gene sequences now available for P. acnes
isolates (via HMP) representing the major phylogroups (IA1, IA2,
IB, IC, II and III) and found mismatches very close to the terminal
39 ends for both the forward and reverse amplification primers
when compared to type II strains (Figure S1). The reverse
sequencing primer also had a T/G mismatch at the penultimate
base of the 39 end when aligned against type II strains (not shown).
We therefore designed new forward and reverse primers that flank
the 59 and 39 ends of the gene and used them for both
amplification and sequencing (see Materials and Methods). The
primers produce excellent amplicon yields and sequencing reads
from all the phylogroups (data not shown).
MLST4 genotyping in practice
To investigate how the MLST4 approach would work in
practice, we analysed a new batch of P. acnes isolates (n = 87)
recovered from a wide range of different clinical sources (Table 2)
and compared the results to those obtained after MLST8 analysis
Table 1. Loci characteristics and discriminatory power of MLST schemes based on four (MLST4) and eight (MLST8) genes.
Loci
Size
(bp) Alleles
No. Polymorphic
sites
% polymorphic
sites p-distancea pb hc dN/dS
Tajima’sD
testd
% discriminatory
index (95%
confidence intervals)
aroE 424 19 38 8.96 2.22% 0.021 0.026 0.147 20.712 47.1 (40.1–54.1)
atpD 453 13 22 4.86 1.00% 0.010 0.016 0.150 21.487 42.3 (35.6–49.0)
gmk 400 12 20 5.00 1.40% 0.014 0.016 0.105 20.725 43.8 (37.1–50.5)
guaA 493 18 32 6.49 2.30% 0.022 0.019 0.025 0.545 70.6 (66.5–74.7)
lepA 452 10 16 3.54 1.20% 0.012 0.013 0.107 20.351 45.5 (38.6–52.5)
sodA 450 14 21 4.67 1.40% 0.014 0.015 0.063 20.244 69.0 (64.4–73.6)
tly 777 23 49 6.31 1.70% 0.016 0.018 0.299 20.337 79.5 (76.8–82.3)
camp2 804 33 79 9.82 2.60% 0.026 0.025 0.295 0.066 83.7 (81.3–86.0)
MLST4 2498 – – – 1.89% – – – – 93.0 (91.3–94.5)
MLST8 4253 – – – 1.50% – – – – 94.0 (92.3–95.3)
ap-distance determined using Kimura Two parameter nucleotide substitution model.
bNucleotide diversity per site.
cAverage number of nucleotide differences per site.
dp.0.1 for all Tajima’s D test results.
doi:10.1371/journal.pone.0070897.t001
Figure 1. Sliding window analysis of nucleotide diversity (p)
within the concatenated sequence of all eight MLST loci (4253
bp). Analysis was carried out using a window size of 200 bp, and a step
down size of 20 bp. The five genes (aroE, guaA, sodA, tly and camp2)
selected for further analysis are indicated.
doi:10.1371/journal.pone.0070897.g001
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(Table 3). The assignment of ST numbers based on four gene
allelic profiles was as outlined in Table S1. A total of 28 STs were
resolved using the MLST4 method and 38 STs by MLST8
(Figure 2; Table 3). Overall, we identified 35 (40%) type IA1
isolates, four (5%) type IA2, 27 (31%) type IB, one (1%) type IC, 15
(17%) type II and five (6%) type III (Figure 2; Table 2). With the
MLST4 scheme, a total of 15 isolates were correctly highlighted as
a new ST based on the identification of a novel allele for one of the
four loci analysed (Table 3). No other novel alleles were identified
when analysis was extended to the atpD, gmk, lepA and sodA gene
sequences for these isolates. With MLST8, a total of 22 novel STs
were discovered; seven of these new STs were not identified by
MLST4 as the novel alleles resided on the atpD, gmk, lepA and sodA
loci (Table 3). In total, the genotype status of 74/87 (85%) isolates
was correctly identified as either a novel ST or an already
described ST (along with phylogroup and CC) by cross-
referencing of the MLST4 allelic profiles to full profiles available
in the database (Table 3). In 12/13 cases where the specific ST
was not correctly identified, or novel genotype highlighted, the
MLST4 allelic profiles still correctly determined phylogroup and
CC membership (Table 3). Only one isolate, 5–1–3, was not
accurately assigned to either CC or ST, but was correctly placed
within phylogroup IC (Table 3).
When data for all isolates from this and our previous study was
combined (n = 372), the MLST4 method resolved a total of 94 STs
with a D value of 93% (95% CI 91.4–94.6). The full MLST8
approach resolved 114 STs with a D value of 94% (95% CI 92.4–
95.2) (p,0.01). In total, the ST for 91% of all the isolates analysed
was correctly determined based on MLST4. Our analyses clearly
demonstrate, therefore, the potential value of the MLST4 method
for genotyping of P. acnes and classification of isolates into groups
with phylogenetic and clinical relevance. Even in the cases where a
smaller number of specific STs cannot be completely resolved
based on this approach, the data generated will still enable an
isolate to be correctly assigned to its phylogroup and CC in almost
all cases. It will still be necessary, however, to conduct ‘full’ MLST
analysis if novel allelic profiles are generated so the MLST
database can be updated or, depending on the epidemiological or
phylogenetic/evolutionary questions being addressed, a deeper
layer of resolution is required for specific lineages.
MLST and phylogenetic analysis of uncharacterised HMP
Propionibacterium species
As part of our ongoing analysis of other propionibacteria that
currently comprise the HMP, we examined four uncharacterised
Propionibacterium isolates currently listed as distinct from other
recognized Propionibacterium species (http://www.ncbi.nlm.nih.
gov/genome/genomes/1140). On the basis of our initial analysis
of 16S rDNA sequences, we unexpectedly found that all these
isolates appeared to represent strains of P. acnes (1485/1486 bp;
99% identity); this was subsequently confirmed based on
phylogenetic analysis of recA and rpoB housekeeping gene
sequences (Figure S2). In keeping with their identification as P.
acnes isolates, it proved possible to characterise the isolates by
MLST8 analysis. The strain 5U42AFAA was identified as ST1
(type IA1; CC1) based on our scheme, and ST29 (type IA1; CC18)
based on MLST9; CC1 and CC18 are synonymous between the
two schemes. Isolate 434-HC2 was ST5 (type IB; CC5) based on
MLST8 and ST36 (type IB; CC36) based on the MLST9
approach. Again, both CC5 and CC36 are synonymous
complexes between the two typing methods. Both 409-HC1 and
CC003-HC2 had the novel genotype ST117 (type IA1; CC4)
based on MLST8 and ST27 (type IA2; CC28) by the MLST9
method. This difference between the two schemes in respect to
their phylogroup classification of both isolates was also previously
observed with the isolate HL025PA1, an ST4 (CC4) based on our
scheme and ST27 (CC28) based on the Aarhus approach [17].
Comparative genome analysis has shown that the genetic distances
between HL025PA1 and CC4 (type IA1) or CC28 (MLST9, type
IA2), calculated on the substitution rates of single nucleotide
Table 2. Summary of phylogroups and their source for 87 isolates analysed by MLST in this study.
Phylogroup
Source Type IA1 Type IA2 Type IB Type IC Type II Type III Total
Normal skin 2 1 8 – 3 5 19
Acne lesion 16 3 – 1 4 – 24
Blood 6 – 3 – 6 – 15
Wound 3 – 4 – – – 7
Abscess 3 – 1 – – – 4
Conjunctiva – – 2 – 1 – 3
Surgical – – 2 – 1 – 3
Intraabdominal 1 – 1 – – – 2
Pleural aspirate 1 – 1 – – – 2
Oral 1 – 1 – – – 2
Joint aspirate – – 1 – – – 1
Heart implant 1 – – – – – 1
Otitis media – – 1 – – – 1
Intrauterine – – 1 – – – 1
Appendix – – 1 – – – 1
Cystitis 1 – – – – – 1
Total 35 (40%) 4 (5%) 27 (31%) 1 (1%) 15 (17%) 5 (6%) 87 (100%)
doi:10.1371/journal.pone.0070897.t002
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Table 3. MLST results generated for 87 P. acnes isolates upon analysis with the four (MLST4) and eight (MLST8) gene schemes.
MLST4 MLST8
Isolate Source Region
Allelic
profile ST/CC Allelic profile ST/CC Phylogroup
KF16 Acne Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
HDN-1 Acne UK 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
IT100EA Acne UK 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
SP64E Acne UK 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
55835 Cystitis Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
3632 Blood Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
4579 Skin Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
12604 Pleural aspirate Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
16634 Acne Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
63006 Acne Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
19107 Abscess Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
20550 Intraabdominal sample Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
M43 Blood Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
50460 Acne Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
64745 Abscess Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
2–2–1 Acne France 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
2–4–6 Skin France 1–3–1–1 ST1/CC1 1–1–1–3–1–1–1–1 ST1/CC1 IA1
1–1–2 Acne France 1–5-8–2 ST2/CC2 1–1–1-5–1–4–8–2 ST2/CC2 IA2
1–3–2 Acne France 1–5–8–2 ST2/CC2 1–1–1–5–1–4–8–2 ST2/CC2 IA2
15614 Blood Hungary 1–3–2–2 ST3/CC3 1–1–1–3–1–1–2–2 ST3/CC3 IA1
26048 Blood Hungary 1–3–2-2 ST3/CC3 1–1–1–3–1–1–2–2 ST3/CC3 IA1
A10 Acne Hungary 1–3–8–6 ST4/CC4 1–1–1–3–1–1–8–6 ST4/CC4 IA1
82964 Wound Hungary 1–3–8–6 ST4/CC4 1–1–1–3–1–1–8–6 ST4/CC4 IA1
94167 Abscess Hungary 1–3–8–6 ST4/CC4 1–1–1–3–1–1–8–6 ST4/CC4 IA1
28585 Blood Hungary 1–3–8–6 ST4/CC4 1–1–1–3–1–1–8–6 ST4/CC4 IA1
6–2–4 Acne France 1–3–8–6 ST4/CC4 1–1–1–3–1–1–8–6 ST4/CC4 IA1
89071 Wound Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
96088 Skin Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
102778 Joint aspirate Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
1945 Pleural aspirate Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
4837 Surgical sample Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
10738 Abscess Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
14179 Blood Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
16703 Otitis media Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
20527 Blood Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
23766 Wound Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
24728 Wound Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
45808 Intrauterine device Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
51056 Intraoral sample Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
58828 Conjunctiva secretion Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
57826 Conjunctiva secretion Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
61489 Appendicitis Hungary 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
1–3–1 Skin France 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
2–4–5 Skin France 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
4–2–8 Skin France 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
4–4–1 Skin France 1–4–8–6 ST5/CC5 1–1–1–4-1–4–8–6 ST5/CC5 IB
6–3–1 Skin France 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
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polymorphisms within the core regions, are very similar and not
significantly different [24]. Furthermore, genomic interrogation
has revealed the presence of genes that are identical or very similar
to those present in CC1 (type IA1), CC3 (type IA1), CC4 (type IA1)
and CC6 (type II). The difference between the two schemes in
their phylogenetic classification of HL025PA1 may reflect the
mosaic nature of its genome sequence, and their analysis of
completely different sets of genes located in different parts of the
genome. A reference document containing MLST data for P. acnes
Table 3. Cont.
MLST4 MLST8
Isolate Source Region
Allelic
profile ST/CC Allelic profile ST/CC Phylogroup
7–2–6 Skin France 1–4–8–6 ST5/CC5 1–1–1–4–1–4–8–6 ST5/CC5 IB
72995 Surgical sample Hungary 15–4–10–10 ST7/CC6 15–4–2–4–2–3–10–10 ST7/CC6 II
44073 Blood Hungary 15–4–10–10 ST7/CC6 15–4–2–4–2-3–10–10 ST7/CC6 II
65763 Blood Hungary 15–4–10–10 ST7/CC6 15–4–2–4–2–3–10–10 ST7/CC6 II
65311a Blood Hungary 17–4–10-10 ST6/CC6 17–9–2–4–2–3–10–10 ST25/CC6 II
76618 Blood Hungary 17–4–10–12 ST30/CC72 17–4–2–4–2–6–10–12 ST30/CC72 II
6167 Blood Hungary 17–4–10–12 ST30/CC72 17–4–2–4–2–6–10–12 ST30/CC72 II
74873 Blood Hungary 1–4–8–21 ST42/CC5 1–1–1–4–1–4–8–21 ST42/CC5 IB
67060 Wound Hungary 1–4–8–21 ST42/CC5 1–1–1–4–1–4–8–21 ST42/CC5 IB
4–2–6a Skin France 1–4–8–6 ST5/CC5 1–1–9–4–1–4–8–6 ST53/CC5 IB
37J+ Skin Brazil 1–18–8–2 ST57/CC2 1–1–1–18–1–4–8–2 ST57/CC2 IA2
29Ca Skin Brazil 17–4–10–12 ST30/CC72 17–4–2–4–4–6–10–12 ST69/CC72 II
28S2a Skin Brazil 17–4–10–12 ST30/CC72 17–4–2–4–4–6–10–12 ST69/CC72 II
5–3–4a Acne France 17–4–10–12 ST30/CC72 17–4–2–4–2–12–10–12 ST72/CC72 II
17A Skin Brazil 7–7–12–23 ST75/CC77 7–6–3–7–5–9–12–23 ST75/CC77 III
32P Skin Brazil 7–7–12–23 ST75/CC77 7–6–3–7–5–9–12–23 ST75/CC77 III
18Sa Skin Brazil 7–7–12–16 ST76/CC77 7–6–3–7–10–9–12–16 ST76/CC77 III
30F Skin Brazil 7–7–12–16 ST76/CC77 7–6–3–7–5–9–12–16 ST77/CC77 III
A9 Acne Hungary 1–15–2–2 Novel 1–1–1–15–9–13–2–2 Novel (ST92; S) IA1
PF3a Acne Hungary 1–3–1–1 ST1/CC1 1–1–1–3–8–1–1–1 Novel (ST93; CC1) IA1
PF9 Acne Hungary 1–10–8–6 Novel 1–1–1–10–1–1–8–6 Novel (ST94; CC4) IA1
PF12 Acne Hungary 1–9–8–6 Novel 1–1–1–9–9–1–8–6 Novel (ST95; S) IA1
12553 Blood Hungary 15–4–24–10 Novel 15–4–2–4–2–3–24–10 Novel (ST96; CC6) II
M34 Wound Hungary 1–3–25–1 Novel 1–14–1–3–1–1–25–1 Novel (ST97; S) IA1
101320 Surgical sample Hungary 1–4–8–34 Novel 1–1–1–4–1–4–8–34 Novel (ST98; CC5) IB
24763 Intraabdominal sample Hungary 1–4–26–6 Novel 1–1–1–4–1–4–26–6 Novel (ST99; CC5) IB
63848 Conjunctiva secretion Hungary 20–4–10–12 Novel 20–4–2–4–2–6–10–12 Novel (ST100; CC72) II
76793a Oral Hungary 1–3–1–1 ST1/CC1 1–1–1–3–1–14–1–1 Novel (ST101; CC1) IA1
M8 a Acne Hungary 1–3–8–6 ST4/CC4 1–1–1–3–1–14–8–6 Novel (ST102; CC4) IA1
19695a Wound Hungary 1–3–1–1 ST1/CC1 1–15–1–3–1–1–1–1 Novel (ST103; CC1) IA1
44261 Blood Hungary 21–3-1–6 Novel 21–1–1–3–1–1–1–6 Novel (ST104; CC1) IA1
56853 Heart implant Hungary 1–3–1–6 Novel 1–1–1–3–1–1–1–6 Novel (ST105; CC1) IA1
46361 Acne Hungary 15–19–10–10 Novel 15–4–2–19–2–3–10–10 Novel (ST106; CC6) II
5–1–3a,b Acne France 9–8–14–6 ST85/S 9–1–4–8–6–8–14–6 Novel (ST107; CC107)IC
2–1–7 Acne France 17–20–10–12 Novel 17–4–2–20–2–12–10–12 Novel (ST108; CC72) II
6–2–3a Acne France 17–4–10–12 ST30/CC72 17–4–2–4–2–15–10–12 Novel (ST109; CC72) II
8–4–1 Acne France 1–3–8–2 Novel 1–1–1–3–1–4–8–2 Novel (ST111; CC2) IA2
IT41EA Acne UK 1–3–27–1 Novel 1–1–1–3–1–1–27–1 Novel (ST112; CC1) IA1
16J Skin Brazil 18–4–20–35 Novel 18–4–2–4–2–6–20–35 Novel (ST113; CC71) II
11Ga Skin Brazil 7–7–12–16 ST76/CC77 7–6–3–7–5–16–12–16 Novel (ST114; CC77) III
aST was not fully resolved or a novel genotype disclosed based on MLST4.
bMLST4 classified isolate as a singleton, but belongs to the novel CC107 group; phylogroup was, however, correctly identified.
doi:10.1371/journal.pone.0070897.t003
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strains that form part of the HMP and other whole genome
sequencing projects can be found at http://pubmlst.org/pacnes.
Classification within the type I phylogroup
Type I isolates were originally classified into type IA and IB
based on the phylogenetic analysis of recA and tly genes [10,11].
More detailed phylogenetic analysis based on MLST8 sequence
data has, however, revealed that all type IA isolates can be further
partitioned into one of two distinct, statistically significant clades,
which we have designated types IA1 and IA2 [17,26]; these two
distinct divisions are further supported at the phylogenomic level
[24]. Within the type IA1 group, we also see a further subdivision
into a number of phylogenetic clusters that essentially correspond
to CC1 (clade IA-1 [27]), CC3 (clade IA-2 [27]) and CC4 (clade
IB-1 [27]) based on MLST8 [17]. Strains within the type IA2 clade
are also distinct based on biotype and contain fewer non-core
genomic regions when compared with type IA1 strains, which may
result from a lack of rearrangement hot spot family proteins [27].
From a medical microbiology perspective, such classifications are
only useful if they are also associated with important traits, such as
the expression of specific virulence factors, pathogenicity, antibi-
otic resistance or association with specific infections or clinical
conditions. In the case of type IA1 CCs, we see a strong association
with moderate-to-serve acne, as described later, while type IA2
strains are only recovered at a level similar to that observed with
type IB (I-2, Aarhus MLST; clade IB-3 [27]) and II strains, which
are generally considered non-acne associated [16,17,24]. This
clinical observation alone should justify their description as a
distinct group from other type IA strains.
While strains within the recently proposed type IC group (which
includes HMP strain HL097PA1) form a phylogenetic clade that is
highly distinct from all type IA strains [17,24,28], they are
nonetheless very closely related as evidenced by the expression of
dermatan-sulphate binding adhesins, the presence of genomic
regions in common with type IA strains, and a strong association
with acne [17,24,28]. For example, our analysis shows that type IC
strains contain a 8.7 kb genomic region found in our previously
described type IA1 and IA2 strains, but not type IB, II or III, that
encodes a glycosidase hydrolyse gene, ABC-type peptide uptake
operon, and chitinase gene [19]. Despite this, differences from
types IA strains do exist at the genomic level, including deleted
regions, and all type IC isolates analysed to date do not ferment
sorbitol and display resistance to anti-acne antibiotics via
mutations in their rDNA genes [17,28].
Phylogroups, STs and human infection
The analysis of a new, large batch of isolates from disparate
clinical sources for this study (Table 2) provided the opportunity to
further build on our previous work examining the relationship
between phylogroups, STs and infection. To facilitate a more
Figure 2. Neighbour-net splits graph of allelic profiles from all 38 STs identified upon MLST analysis of 87 P. acnes isolates. STs
representing all phylogroups were identified from this cohort of isolates. Parallelogram structures indicative of recombination events are evident
within the major type I and II divisions.
doi:10.1371/journal.pone.0070897.g002
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robust analysis, data from the isolates used in this (n = 87) and our
earlier study (n = 285) were combined (n = 372) (Table S2). The
data demonstrates that STs from the P. acnes type IA1 group (CC1;
CC3; CC4) strikingly dominate isolates cultured from acne-
affected regions (73%), while those from the type IA2, IB, IC, II
and III groups are either recovered at much lower rates (,10%
per group) or never recovered (type III) (Figure 3) [9,16,17,24].
With isolates recovered from normal facial and upper back skin
(n = 97) we find a somewhat more even distribution (p,0.001)
(Figure 3). While key STs associated with moderate-to-severe acne
(ST1, ST3, ST4) are present in normal skin, they appear
particularly enriched in the acne-related samples; particularly
ST3 (CC3). For example, ST1 and ST3 alone represent 26% and
14%, respectively of acne isolates, but only 15% and 4%,
respectively of isolates from normal skin (Table S2). The ST3
lineage also appears especially associated with rRNA point
mutations conferring resistance to tetracyclines, erythromycin
and clindamycin [17]. As acneic and normal pilosebaceous follicles
will co-exist together on the skin of acne sufferers, it is likely that
some type IA1 strains isolated from acneic skin will not directly
relate to the condition when sampling from follicles [16,17,24].
Despite this, the high statistical significance relating type IA1 with
this common skin condition does provide evidence for a
meaningful association. Similar conclusions being reached in
different independent studies also provides evidence for this
association [16,17,24]. For example, Fitz-Gibbon et al. [24] found
ribotypes 4/5 and 8, which are synonymous with the MLST8
genotypes ST3 (CC3) and ST4 (CC4), respectively are enriched in
acne patients, but ribotypes representing type IA2 strains show no
statistically significant association with the condition. While the
apparent capacity of type IA1 strains to contribute to the
pathophysiology of acne over other phylogroups remains unclear,
we can speculate that it may reflect an enhanced ability to adapt to
the changing environment created as a normal follicle develops
into a lesion. Strains from this division also appear to display
increased inflammatory potential and the expression of putative
virulence factors, such as dermatan sulphate-binding adhesins
(PA25957/PPA2127, DsA1; PA5541/PPA2210, DsA2), which
may play important roles in the disease process. The latter cell
surface molecules have hypermutable homopolymeric tracts
upstream of a putative signal peptide that may give rise to
slipped-strand mispairing during replication resulting in either
phase or antigenic variation that may be important in immune
evasion or adaption to environmental changes [9]. These proteins
also have variable numbers of PT repeats towards the mid-region
and the carboxyl-terminus that generates differences in molecular
mass, as well as the absence of an ATG start codon in type IB
strains [9]. Such phase variable adhesins are also found in
‘classical’ pathogenic species, including the SabA adhesin of
Helicobacter pylori which is implicated in binding to the host gastric
epithelium [29]. Epitope mapping studies of DsA1 indicate that
the region towards the amino-terminus of this polypeptide is
recognized by antibody in serum from acne-positive individuals
and contains a CD4+ T cell epitope [13]. At the genomic level ST3
strains contain unique regions that are believed to have originated
from mobile genetic elements and encode virulence genes [24],
while ST4 strains contain a distinct 20 kb island that encodes
nonribosomal peptide synthetases which may contribute to
increased virulence [27]. With the MLST8 scheme we have found
that the large majority of isolates from acneic regions of the skin
(,85%) that we previously classified as ST6 (CC6) based on the
original Warwick MLST7 protocol [9] retain the same ST when
revisited with the enhanced resolution of the expanded method
(ST1; CC1) confirming our conclusions regarding the clonal
nature of this set of isolates. Similarly, reanalysis of type IB isolates
originally identified as genotype ST10 (CC10) [9] revealed the
same ST (ST5) in nearly all cases (90%) by MLST8; type IBs
represent a tight phylogenetic cluster with a simple CC structure
and strongly predicted founder (ST5; 89% bootstrap value) which
indicates a relatively young age. These results therefore validate
our previously described conclusions regarding the identification
of disseminated clonal lineages, backed up by RAPD analysis [9],
and the apparent association of a dominant type IA1 epidemic
lineage with the skin of acne patients [9]. In addition to acne, we
also observed significant numbers of type IA1 strains isolated from
ophthalmic and other soft tissue infections, as well as blood
samples (ure 3), including the common acne-associated lineages
ST1 (CC1), ST3 (CC3) and ST4 (CC4); this suggests a broader
Figure 3. Association of P. acnes phylogroups with different clinical conditions and normal skin. Data was obtained from MLST analysis
of 372 isolates.
doi:10.1371/journal.pone.0070897.g003
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pathogenic potential. In keeping with this, we have found that the
recently completed whole genome sequence of the P. acnes isolate
C1 [30] (Genbank accession no. CP003877.1), recovered from a
Japanese patient with sarcoidosis also represents a type IA1 strain
belonging to CC3 (new genotype ST115; 1–1–1–3–1–1–22–2) (not
included in this study). During this study we also identified a novel
type IC genotype, ST107 (Table 3; Table S2); this brings the total
number of isolates currently identified for this group to five (three
STs). In keeping with previous observations, the ST107 isolate
cross-reacted with mAbs primarily specific for types IA (QUBPa1)
and II (QUBPa2) [17,28].
While STs from the type IA2, IB, II and III groups do not
appear to commonly represent isolates Figfrom acneic regions of
the skin, a heightened role in medical device and soft tissue
infections is suspected [16,17], and results from our current MLST
isolate collection do lend some support to this view (Figure 3). Of
particular note, type II isolates are commonly associated with
blood and medical devices, and type IB isolates with medical
devices and soft tissue infections; although it is unclear whether
such associations are clinically meaningful in many instances. The
number of type IA isolates associated with medical devices is low
based on our current but large MLST collection; and somewhat in
contrast to our previous antibody typing studies in 2005 which
found levels almost equalling those of type II strains, with little
evidence for type IB, based on a different set of 40 isolates
recovered from prosthetic hip joint sonicates [11]. Further studies
are required to conclusively determine whether type IB and II
lineages truly have an increased potential to colonise and
subsequently cause downstream medical device-related infections.
Relevant to our observations on soft tissue infections is a recent
study which found that P. acnes isolates from cancerous prostate
tissue (n = 10) belong to either the type IB (30%) or type II (70%)
divisions [31]. This fits with our more recent MLST8 publication
which similarly found a predominance of type IB (45%; ST5 and
ST53) and type II (33%; ST6, ST65 and ST67) genotypes, and to
a lesser extent type IA1 (22%; ST4 and ST21), amongst a small
collection of P. acnes isolates recovered from cancerous prostate
tissue (n = 9) [17]. Another study on 24 P. acnes isolates retrieved
from the cancerous prostate tissue of Swedish patients identified
the majority as type II (67%), with similar numbers of type IA
(21%) and type IB (12.5%) [22]. Combining the typing data from
all three independent studies therefore provides support for an
association between lineages from the type II phylogroup and
cancerous prostates (61% of all isolates; p,0.001). While a
possible role for P. acnes in prostate cancer development remains
controversial, the dominance of STs from this phylogroup over
strains from the type I division does provide some evidence to
support the view that isolation of P. acnes from cancerous prostate
samples cannot simply be dismissed as contamination from the
skin, at least not in all contexts; this confirms the original seminal
observations of Cohen et al. [7]. The observation that type II
strains appear capable of causing greater long term infection in a
rat model of prostatic inflammation (three months post-infection)
when compared with type I strains would therefore appear an
important observation when combined with emerging epidemio-
logical data; although bacterial counts were very low [32]. It still
remains to be determined, however, whether the presence of P.
acnes in human prostates may arise from the urethra, especially as
type IB and II lineages do appear more common inhabitants of
this environment [19], or post-cancer colonisation of hypoxic
regions within already growing prostate tumours. Further studies
will undoubtedly address these issues. An interesting observation
from the analysis of our current isolate database was the relatively
high proportion of type III isolates that were associated with spine
intervertebral disc material (excised disc protrusion) (Figure 3). We
first identified type IIIs as representing a novel P. acnes phylogroup
in 2008, again mostly in association with spinal disc material [15],
which was an interesting observation as P. acnes had been
described as a possible cause of sciatica [33]. Since then, there
has not been any definitive evidence to suggest this lineage is
responsible for infection. Indeed, we previously found lineages
from this group (ST32, ST75, ST76 and ST77) only in association
with healthy skin, tentatively suggesting they may represent ‘true’
commensals [17]; whether such strains with no pathogenic
potential do exist has yet to be conclusively established. Proteomic
studies with the type III strain 487 have also found that when
compared with other phylogroups (IA1, IB, & II), it produces fewer
detectable secreted proteins after growth in complex media [34].
In the context of their main ‘clinical’ isolation sources to date,
primarily spinal disc tissue, and medical devices [15,17], it will be
important to ascertain if this association is real or whether it simply
reflects contamination of surgical sites with skin microbiota. This
will be important since previous studies have shown that
contamination of spinal incision sites during surgery can occur,
even after pre-operative skin antisepsis and antimicrobial prophy-
laxis [35].
Clonal diversification within P. acnes: mutation versus
recombination
We have previously shown that the overall P. acnes population
structure is clonal and in linkage disequilibrium based on index of
association (IA) analyses for our entire isolate collection, as well as
unique STs [9,17]. We also observed a reduction in the IA value
when only STs were considered, which is also in keeping with an
epidemic population structure where highly successful clonal
lineages emerge and become widely dispersed [9,17]. This
supports observations that particular MLST lineages are especially
prevalent and can display intercontinental spread as a result of
human migration [16,17]. A similar epidemic population structure
is also seen with the other Gram-positive skin commensal,
Staphylococcus epidermidis [36]. No evidence of statistically significant
recombination was identified in either the housekeeping or
putative virulence gene sequences using the phi test (Figure S3),
although for a number of the loci (eg., aroE, guaA, sodA) split
decomposition graphs did suggest limited recombination events
due to the presence of interconnected pathways (Figure S3); again
consistent with our previous study which found non-congruence
between some housekeeping gene trees [9]. Analysis of concate-
nated sequences from the population as a whole, however, did
reveal levels of recombination that were statistically very
significant (phi test p = 0.001).
To estimate the roles that mutation and recombination play in
generating clonal diversification within P. acnes, the r/m parameter
was calculated. Such analyses are important if we are to
understand how recombination contributes to the evolution of
this bacterium, particularly in the context of antibiotic resistance
and current discussions around vaccine development. Based on
our current database, which is now sufficiently diverse for such an
analysis, a total of nine CCs have been identified providing a total
of 84 single locus variants (SLVs) for analysis (Figure 4; Table 4).
The previously described type IA1 CCs, CC1 and CC4 now form
two clusters within a large single complex, with ST1 as the founder
(100% bootstrap) and ST4 (98% bootstrap) as a sub-founder; these
two clusters are linked via ST105 which contains a recA gene
sequence identical to that from NCTC737 (ST1; CC1) (Figure 4).
A total of 39 variants were from the type IA1 group, five from type
IA2, nine form type IB, two from type IC, 20 from type II and nine
from type III. A total of 45 SLVs had alleles that differed at only
P. acnes: Human Disease & Evolutionary Insights
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one nucleotide site from the ancestral ST and were not present in
any other STs within the database; these SLVs were considered to
have arisen by de novo mutation (Table 4). A total of 20 SLVs also
had alleles that differed at only one nucleotide site from the
ancestral ST, but these alleles were also present in other STs
within the database. Of these, seven were still considered to have
arisen by mutation as their presence in other STs clearly appeared
to reflect vertical descent based on eBURST analysis, while the
remainder were classified as recombination events (Table 4). The
remaining 19 SLVs all had more than one nucleotide difference
consistent with recombination. For the population has a whole, the
per-allele r/m parameter was calculated as 1:1.6 and the per-site r/
m parameter as 3:1 using this current dataset. This demonstrates
that for P. acnes, alleles are marginally more likely to change by
mutation (,1.5-fold) but individual nucleotide sites by recombi-
nation. While rates of recombination within P. acnes are less than
that found in many other bacterial species, levels are still
sufficiently high to ensure an important role in the evolution of
the bacterium, and this plasticity in the gene pool has been further
evidenced by the analysis of whole genome sequences which
reveals mosaics within the population [37].
Intra-phylogroup recombination
While P. acnes is in linkage disequilibrium overall, we previously
observed that the association between alleles appears less
significant within the main phylogroups [17]. This suggested that
rates of horizontal gene transfer may differ throughout the
population. With our increased MLST data set, we explored this
possibility in more depth by examining IA values within types IA,
IB, II and III. Within the type I clade (IA1, IA2, IB, IC), IA values
were still consistent with linkage disequilibrium when all isolates
and STs were analysed (p,0.001) (Table 5), but a consistent
reduction in IA values was observed indicating that the association
between alleles was less significant. A similar pattern was observed
when isolates and STs from the IA cluster (IA1, IA2) were just
considered (Table 5). In both cases, levels of recombination within
the groups were significant by the phi test (Table 5), and evidence
of reticulation indicative of recombination events within the type
IA group also evident upon splits graph analysis (Figure 2). With
the type II division population, linkage disequilibrium was
detected when all isolates were considered, although the IA value
was low (IA 0.0485), but linkage equilibrium was identified when
only STs from our updated dataset were analysed (IA 20.0201;
p.0.1). While levels of recombination were non-significant by the
phi test, this was marginal and clear evidence of potential
recombination events within the type II cluster were observed
within the splits graph (Figure 2). Similarly, with the type IB
phylogroup, linkage disequilibrium was detected with isolates and
linkage equilibrium with just STs (Table 5). This difference likely
reflected the dominant presence of ST5 (CC5) within this
population producing a dilution in the observed effect of
recombination. There was, however, no statistically significant
measurement of recombination by the phi test. With the type III
phylogroup we observed linkage equilibrium when both isolates
and STs were considered, but no evidence of recombination was
detected by the phi test (Table 5). With both the type IB and III
populations, however, sample sizes were smaller and this could
affect the statistical robustness of the linkage analysis in these cases
[38].
Figure 4. eBURST population snapshot of the current P. acnesMLST database. To date, a total of nine clonal complexes, where the isolates
share 7/8 loci with at least one other ST in the group, and 21 singletons have been identified. The frequency of each ST within the isolate database is
indicated by the size of each circle. Founding genotypes are highlighted in blue and sub-founders in yellow. The previously described separate
complexes CC1 and CC4 now form a large single complex with ST1 as the founder (100% bootstrap) and ST4 (98% bootstrap) as a sub-founder; these
two clusters are linked via ST105. Note, the spacing between the singletons and clonal complexes is not related to the genetic distance between
them.
doi:10.1371/journal.pone.0070897.g004
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The observation of heightened rates of horizontal gene transfer
(HGT) within, but not between, the large type I and II
phylogroups may reflect the very recent observation that type II
lineages contain clustered regularly interspaced short palindromic
repeats (CRISPR)/Cas loci which confer immunity to bacterio-
phages and foreign mobile genetic elements [27,39]. Sequence
analysis of CRISPR spacers in type II strains has found evidence of
previous challenges from P. acnes-specific phages and two mobile
genetic elements that are found almost exclusively in type I P. acnes
strains [39]. The CRISPR/Cas system may therefore restrict the
acquisition of horizontally transferred DNA from the type I
division; although some sharing of alleles between the type I and II
clusters was observed (Table 4). Reduced rates of horizontal gene
transfer between types I, II and III are also likely to reflect
ecological differences, with recombination being much more likely
between members of the same habitat. We can speculate that
adaptation to specific ecological niches within the human host
(Ecotype model) [40], as opposed to genetic drift, has been the
primary driver behind the emergence of the major lineages of P.
acnes. This may also explain, at least in part, the differences in
opportunistic infection profile.
Selective pressure on ‘putative’ virulence loci
All housekeeping gene loci had dN/dS ratios consistent with
stabilising or negative selection (,1.0). Furthermore, Tajima’s D
values did not deviate significantly from zero (p.0.1) consistent
with a null hypothesis of mutation-drift (neutral) evolution
(Table 1). In keeping with our earlier observation that the putative
virulence genes tly and camp2 had levels of genetic diversity similar
to the housekeeping loci, we also observed dN/dS ratios ,1.0
(Table 1) and values for Tajima D (Table 1), as well as Fu and Li’s
test of selection (data not shown), that were not significantly
different from zero whether using distinct allele sequences or those
from the complete isolate collection. This is in line with our
previous investigations which demonstrated that these genes
displayed no clear evidence of diversifying selection by SLAC
(p,0.1 threshold), MEME (p,0.05 threshold) or PARRIS (p,0.1
threshold) analyses using recommended cut-off values [17].
In this study, we scrutinised the tly and camp2 gene sequences in
more detail using alternate FEL and REL tests of selection [41].
Under the FEL model (p,0.1 threshold), which is especially
valuable with intermediate-to-large datasets, no evidence of sites
under diversifying selection were identified for either gene using
both REV and HKY85 models of substitution. For camp2,
however, a total of 15 sites were identified as being under negative
selection with the HKY85 model of substitution and 18 sites using
REV; these reduced to five and seven sites, respectively when a
threshold of p,0.05 was set. With the tly gene, six sites were
identified as under negative selection with HKY85 and four sites
with Rev; these both reduced to zero at p,0.05. With the REL
model (Bayes factor threshold of 50), which is useful for small or
low divergence alignments, no sites were identified as being under
diversifying selection for camp2 using both HKY85 and REV, but
33 were highlighted as being under negative selection. These
results did not change at a Bayes factor threshold of 100. For the
tly gene, no negative sites of selection were identified using either
HKY85 or REV models. Three sites were identified as being
under potential diversifying selection with REV; this reduced to
zero at a Bayes factor threshold of 100. With HKY85, no
diversifying or negative sites of selection were identified. These
analyses, combined with other tests of selection, provide little
evidence for any positive selection in the history of these putative
virulence genes. Although REL highlighted three marginally
significant tly sites that may be under diversifying selection using
the REV model of substitution, the results were inconsistent with
the many other tests of selection. As REL is susceptible to false
positive results, the biological significance of these sites remains
uncertain. Overall, the results are concordant with the view that
these putative virulence loci have co-evolved alongside house-
keeping genes [16,17]. This helps explain why previous analyses
with tly and camp2 gene sequences generate phylogenetic trees that
are essentially congruent with those based on housekeeping loci
[10,11].
CAMP factor 2 and Tly: more than just virulence proteins?
P. acnes is unusual in that its genome codes for an expanded
family of five CAMP factor homologues, with putative N-terminal
signal peptide cleavage sites, which appear to be expressed at
different levels between phylogroups [10]. Amino acid sequence
identity between these homologues varies from approximately
35% to 50%. Although the function of these putative virulence
proteins in P. acnes has not been clearly resolved, in vitro studies
provide some evidence that CAMP2 may be an important co-
haemolytic factor [42,43]. Previous in silico analysis has also
demonstrated some sequence identity between the Fc-binding
region of Staphylococcus aureus protein A and P. acnes CAMP factors
1 and 3 suggesting they may have immunoglobulin-binding
capabilities [10]. Other studies have shown the protein to display
cytotoxic properties against keratinocyte (HaCaT) and macro-
phage (RAW264.7) cell lines, and to stimulate skin inflammation
in mouse ears [43]. Passive immunization of mice with anti-CAMP
factor serum abrogates P. acnes–induced inflammation in this
model; although this is clearly not an appropriate system to mimic
the unique and harsh environment found within an inflammatory
acne lesion. These cytotoxic effects may reflect, in part,
interactions between CAMP2 and host cell acid sphingomyelinase
Table 5. IA values for isolates and STs from the whole P. acnes
population and major phylogroups (IA, IB, II & III).
p value
Collectiona IA value Parametric Simulation phi test
All
Isolates (n = 372) 0.4847 ,0.001 ,0.01 –
STs (n = 114) 0.3778 ,0.001 ,0.01 0.001
Type I
Isolates (n = 288) 0.1960 ,0.001 ,0.01 –
STs (n = 75) 0.1180 ,0.001 ,0.01 0.001
Type IA
Isolates (n = 216) 0.1412 ,0.001 ,0.01 –
STs (n = 61) 0.0437 ,0.001 0.03 0.005
Type IB
Isolates (n = 67) 0.0548 ,0.001 ,0.01 –
STs (n = 11) –0.0204 1.000 0.69 1.000
Type II
Isolates (n = 53) 0.0485 ,0.001 ,0.01 –
STs (n = 28) 0.0201 0.187 0.150 0.096
Type III
Isolates (n = 31) –0.0546 1.000 0.920 –
STs (n = 11) –0.0021 1.000 0.630 1.000
aType IC not included as a separate group as sample size too small.
doi:10.1371/journal.pone.0070897.t005
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[43]. In contrast, studies with a camp2 knock-out gene mutant did
not find any significant alteration in the transcriptomic response of
HaCaT keratinocyte cells to P. acnes, but camp 4 knockout mutants
did cause the deregulation of 29 genes, including sphingomyelin-
ase 3 [42]. The suggested pathogenic role of camp2 has led to its
proposal as a potential therapeutic target for the treatment of acne
and other P. acnes-related diseases via passive immunoprotection
with human monoclonal antibodies or vaccination [43,44].
Putative targets for immunotherapy should ideally contain no
evidence of any positive selection; such pressures may lead to the
generation of variable epitopes that compromise future clinical use
[45]. The demonstration that camp2 gene sequences display no
clear evidence for episodic or pervasive positive selection using a
broad range of selection tests, and appear to experience a very
modest rate of recombination (phi test p = 0.727), may be
important observations in the context of its proposal as a cell
surface immunotarget. The r/m parameter values calculated for
camp2 (1:1.4 per allele; 1.7:1 per site) and also tly (1:1.6 per allele;
1.6:1 per site) fall within the range of values determined for the
housekeeping loci, further arguing for their co-evolution with the
core genome [17]. The observation that camp2 and tly experience
evolutionary forces more in keeping with housekeeping genes is in
contrast to that often observed with cell surface-associated proteins
from other bacterial species, where increased diversity, mosaic
allele structures and evidence of positive selection are present [46].
In the case of P. acnes, this may simply reflect a lack of
Figure 5. Alignment of CAMP factor 2 amino acid sequences from P. acnes type strain NCTC737 (type IA1; ST1; CC1) and P. humerusii
strains HL044PA1, HL037PA2, HL037PA3 and P08. Overall identity between the homologues from these two species based on their protein
sequence is 92%. The N-terminal putative signal sequence cleavage site occurs at the AHA-VE sequence (start residue position, 26).
doi:10.1371/journal.pone.0070897.g005
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immunogenic pressure within the cutaneous environment; future
more detailed analysis of the different selective pressures acting on
other secreted/cell surface-associated proteins of P. acnes may help
establish this possibility. Co-evolution with the core genome may
also provide some evidence that these putative virulence genes
play important roles in the commensal/normal existence of P.
acnes, as well as a pathogenic lifestyle, thus constraining their
functional diversity and preventing their loss from the population
[16,17]. The apparent detection of purifying selection upon
analysis of the camp2 gene using FEL and REL tests provides some
support for this alternate view, at least for this locus; with tly we did
also find some suggestion of negative selection with the REL test,
but this was at best limited and only marginally significant. In
relation to CAMP factor 2, previous immuno-detection and
proteomic studies have observed the production of this protein in
all strains examined [10,34]. These include strains from the type II
and III phylogroups, which appear to contain lineages which may
be ‘true’ commensals. There is a growing recognition that the term
‘virulence factor’ may need to be redefined, and when such
determinants are also widely disseminated in commensal strains
the term ‘niche factor’ or ‘host adaptation factor’ may be more
appropriate to reflect their potential importance in colonisation
and survival within the host [47]. Even local damage to host cells
in the surrounding milieu of a bacterial cell may prove beneficial
in this context, providing particular micronutrients for survival
and persistence [47]. Examples of potential ‘niche factors’ include
BilE for gastrointestinal survival in Listeria and Tad IV pili in
Bifidobacterium breve [48,49]. Also, an example of a virulence factor
with an important dual function is the PEB1a protein of
Campylobacter jejuni, a cell surface antigen with a major role in
adherence and host colonisation, but also a periplasmic binding
protein component of an aspartate/glutamate ABC transporter
essential for optimal microaerophilic growth [50]. It is important
to remember that skin commensals also have to compete with
other microbiota for survival, growth and immune evasion. On
this basis, the mechanisms adopted to achieve these lifestyle
challenges are likely to overlap somewhat with those utilised by
pathogenic strains [47]. Of particular relevance to this study are
recent investigations which suggest a role for Tly other than just a
hypothetical haemolysin/ cytotoxin in Mycobacterium tuberculosis, a
member of the order Actinomycetales to which P. acnes also belongs
[51,52]. It has been proposed that the Tly protein family needs re-
annotating and redefining as an RNA-binding FtsJ-like methyl-
transferase involved in ribosomal biogenesis [52]; the M. tuberculosis
Tly lacks a signal peptide and transmembrane helices consistent
with cytoplasmic localization [52]. We have similarly found no
evidence for a signal sequence cleavage site within P. acnes Tly
proteins (data not shown). While it is unclear how this work relates
to the Tly protein of P. acnes, which is 50% identical to the M.
tuberculosis Tly sequence, it could provide one explanation for the
absence of clear diversifying selection within the gene which
actually functions as a housekeeping methyltransferase, possibly
alongside a role as a haemolysin [51].
CAMP factor homologues in other human
propionibacteria
The evolutionary history of CAMP factor homologues in P.
acnes has not been addressed; and there is no evidence for their
presence in the genome sequences of the non-cutaneous ‘dairy’ or
‘classical’ group species Propionibacterium freudenreichii subsp. shermanii
(CIRM-BIA1; GenBank accession no. FN806773) or Propionibac-
terium acidipropionici (ATCC4875; GenBank accession no.
CP003493), suggesting a potential role in human colonisation
[53,54]. To investigate whether CAMP homologues are present in
other human propionibacteria, we interrogated the available
whole genome sequences of Propionibacterium propionicum (F0230a,
GenBank accession no. CP002734), the newly described sister
taxon of P. acnes, Propionibacterium humerusii (P08, GenBank
accession no. NZ_AFAM00000000; HL037PA2, GenBank acces-
sion no. ADYH00000000; HL037PA3, GenBank accession no.
ADXV00000000 and HL044PA1, GenBank accession no.
ADZU00000000) [55], and Propionibacterium avidum (ATCC25577,
GenBank accession no. AGBA00000000; 44067, GenBank
accession no. CP005287 [56]).
Although our in silico analysis provided no clear evidence of any
CAMP factor genes in P. propionicum, a species responsible for
actinomycosis and ondodontic infections [57], nucleotide sequenc-
es representing all five homologues were identified in the genome
of P. humerusii strains. Intact camp2, camp3 and camp5 gene
Figure 6. MAUVE visualisation of synteny between P. acnes, P. avidum and P. humerusii genomes. Pairwise alignments of genomes were
generated using the progressive MAUVE algorithm (v2.3.1). The sequence similarity in the pairwise alignment of P. acnes (6609, type IB ST5, CC5) and
P. avidum (ATCC25577) was 53.2%. The similarity between P. acnes (6609) and P. humerusii (P08) was 69.3%, and between P. avidum (ATCC25577) and
P. humerusii (P08) 52.7%.
doi:10.1371/journal.pone.0070897.g006
P. acnes: Human Disease & Evolutionary Insights
PLOS ONE | www.plosone.org 16 September 2013 | Volume 8 | Issue 9 | e70897
sequences were present in all four strains, and the resulting amino
acid sequences had high identities, ranging from 84–98%, when
compared to their equivalent homologues in the P. acnes type strain
NCTC737 (type IA1 lineage; ST1) which we chose for comparison
(Figure 5; Figure S4). In particular, the CAMP3 protein displayed
a very high identity with its P. acnes counterpart (98%). The
CAMP1 protein in the HMP strains HL037PA2, HL037PA3 and
HL044PA1 also had a high level of amino acid identity (91%) to
the CAMP1 homologue in P. acnes (Figure S4), but strain P08 had
a camp1 gene sequence that gave rise to a truncated protein
product (data not shown). The genome from strain P08 is still at
the draft assembly stage and it is, therefore, unclear if this reflects a
true result or a currently uncorrected sequence error. The camp4
gene, while present in all four strains, appears to give rise to a
truncated product that is ,55% of the length of the equivalent
homologue in NCTC737; this appears to have arisen via the
introduction of a stop codon. No clear evidence for CAMP factor
homologues 1, 2 and 4 was found in the genomes of P. avidum, but
camp3 and camp5 genes were present with amino acid identities of
92–93% and 80%, respectively when compared to the equivalent
homologues in both P. acnes and P. humerusii (Figure S4). We also
examined the presence of the CAMP factor homologues in the
Propionibacterium isolate SK182B-JCVI, which is currently being
sequenced as part of the HMP. While the 16S rDNA sequence of
this isolate shares approximately 99% identity with the sequence
from P. acnes NCTC737, it is clearly a distinct taxon from all other
P. acnes strains when more rapidly evolving protein-encoding
housekeeping loci, such as recA (91% identity) and particularly rpoB
(89–91% identity), are considered (Figure S2); within P. acnes, the
main genetic divisions (types I, II and III) are 98–99% identical
based on both recA and rpoB. Further analyses will be required to
determine the exact relationship of this strain to P. acnes and other
propionibacteria. Within this novel taxon, four CAMP factors
were identified; three of the amino acid sequences matched
CAMP factor 2 (80% identity), CAMP factor 3 (99% identity) and
CAMP factor 4 (91% identity) when compared to their equivalent
homologues in P. acnes NCTC737. The fourth sequence had 65%
identity to CAMP factor 1 and 55% identity to CAMP factor 5.
The relationship between CAMP factor homologues and propi-
onibacteria based on available genome data is illustrated in
Figure S5.
The generation of protein families in prokaryotes, as in
eukaryotes, has been assumed to result primarily from intrage-
nomic gene duplication events generating paralogue gene
sequences [58]; genome duplications in organisms can result from
ancestral whole genome duplications, followed by massive gene
loss and specialization, or by duplication of a single gene or group
of genes [59]. One very recent study has, however, challenged this
view and suggested that expansion of gene families in bacteria via
HGT and incomplete xenologous gene replacement may be much
more important than first thought [60]. While duplicated
sequences are often co-localized as tandem repeats, genome
rearrangements/plasticity may complicate this picture resulting in
the dispersal of paralogs throughout the chromosome; in contrast,
xenologs should be randomly distributed as a result of HGT [60].
In the case of the CAMP factor gene family, camps 1, 4 and 5 lie
within a relatively limited region of the whole P. acnes genome (type
IB isolate 6609; positions 1305067–1462007), while camp 2
(position 756691–757494) and 3 (position 2282724–2283539) are
more widely dispersed. In regards to gene duplication, it provides
an opportunity for a rapid period of genetic change due to relaxed
selective constraints, and represents a significant mechanism for
the emergence of genes with the same, altered or novel cellular
functions via mutation, drift and selective pressures [61]. Based on
our current understanding, these include ecoparalogs, which are
functionally equivalent genes adapted to perform under different
ecological conditions [62], subfunctionalization, where the ances-
tral functions are partitioned between paralogue sequences [63]
and, less frequently, neofunctionalization, which generates a new
function in one of the duplicates which is subsequently maintained
by purifying selection [64]. In contrast, because xenologs are
related but distinct proteins they can generate an advantageous
new function immediately upon integration to the genome, thus
providing a potent method of innovation and long-term adaptive
expansion of protein families [60].
On the basis of previously described co-localization and
sequence similarity criteria [60], and the assumption that genomic
rearrangements occur at a low rate, it would appear that HGT has
played some role in the expansion of the CAMP factor family.
Irrespective of the exact genetic mechanism(s) and series of events
underlying expansion of the CAMP factor protein family, we can
be certain that evolution of this family was a pre-speciation event.
The observation of similar genomic locations amongst equivalent
CAMP homologues in different propionibacteria provides evi-
dence to support this view (Figure S6). On the basis of a gene
duplication model, CAMP factor homologues would, therefore,
represent ‘out-paralogs’ (alloparalogs). Using the data currently
available from whole genome sequencing projects we can now
propose a hypothetical scenario for CAMP factor evolution in
propionibacteria via expansion of this protein family in a lineage
that gave rise to a common ancestor of P. acnes, P. humerusii,
P. avidum and P. propionicum. While the exact biological role played
by each CAMP factor still remains to be determined, the distinct
amino acid identities observed between members of the family
may highlight possible functional differences. The presence in
P. humerusii of four CAMP homologues, with high amino acid
identity to those in P. acnes, again highlights the close taxonomic
relationship between these species, and indicates that the
respective proteins may perform similar functions in both taxa;
the presence of a stop codon in the camp4 sequence of P. humerusii
suggests this protein is no longer expressed in an active form in this
species. The absence of CAMP factors 1, 2 and 4 in P. avidum and
all CAMP sequences in P. propionicum, the closely related sister
taxon of P. avidum, leads us to tentatively suggest that in these
descendant species their presence has not proven beneficial and,
consequently, they have been deleted from the genome over time;
gene loss due to a lack of fitness is a common feature of the
evolutionary process, although xenologs appear to persist longer
than paralogs possibly as a result of greater adaptive roles [60].
This process may also occur to remove genes whose function
interferes with the invasion of a new niche [65]. These
observations are consistent with the idea that in P. humerusii and
P. acnes, camp gene sequences may encode proteins that have some
degree of functional diversity, and provide a selective advantage
(eg., metabolically and /or ecologically) for their existence within
the human host as niche/ host adaptation factors, in addition to
their role in as putative virulence factors, hence their retention
within these genomes. Circumstantial evidence that supports such
a possibility has come from immunofluorescence studies with a
monoclonal antibody to CAMP factor 1, which has shown
expression of the protein amongst both follicular and epidermal
P. acnes populations in healthy/normal skin [66]. Interestingly,
P. humerusii, like P. acnes, has been found in the extreme and
stressful environment of the pilosebaceous follicle providing
evidence that it may have the capacity to survive within similar
environmental niches [24]. Although the original strain was
isolated from the humeral membrane of a patient who underwent
revision of a failed total shoulder arthroplasty, the ability of this
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species to cause opportunistic infections has yet to be firmly
established [55]. In contrast, water and substrate availability
appear dominant forces in the ecology of P. avidum which
preferentially colonises moister areas of the skin, such as the
vestibule of the nose, axilla and perineum; P. propionicum is
primarily isolated from the oral cavity, although it may not
actually represent part of the normal human microbiota [67].
While previous studies based on the analysis of P. acnes grown on
anaerobic blood agar plates and brain heart infusion broth have
demonstrated CAMP factor expression [10,34], such data for
homologues in P. humerusii and P. avidum are currently not
available; such studies will be essential if we are to further
investigate a possible role in commensal existence. For almost all of
the CAMP factor protein sequences examined from P. humerusii, P.
avidum and SK182B-JCVI, the characteristic -AXA- N-terminal
putative signal sequence cleavage site is present, with the exception
of the P humerusii CAMP 1 factor where a -VHA- motif replaces -
AHA- in P. acnes (Figure S4). Future work will hopefully
determine the exact functions of the different camp genes in P.
acnes and whether their retention within the genome does indeed
reflect adaption to changing environments. This information,
combined with emerging genome data for other Propionibacterium
species, will enable us to further explore and discuss different
aspects of this possible CAMP factor evolution scenario and, if
necessary, refine or change the hypothesis in light of new data.
CAMP factor 2 protein as a therapeutic target?
If CAMP2 and indeed other CAMP factor homologues do play
an important role in the survival of P. acnes within the human host,
as well as contributing to a pathogenic lifestyle, then we could
speculate that selecting CAMP2 as a therapeutic target may
potentially impact on those lineages associated with maintaining
health, in addition to those with a heightened capacity to cause
disease. The potential relevance of this issue has been highlighted
by a study demonstrating that fermentation of glycerol by P. acnes
can function as a skin probiotic for growth suppression of
community-acquired methicillin-resistant Staphylococcus aureus
[68]. Unintended targeting of commensal lineages may, therefore,
impact on the skin’s ability to prevent colonisation and infection by
more pathogenic organisms. This is likely to prove more of an
issue for CAMP factor-targeted vaccines, rather than local
targeting of secreted CAMP factor in acne lesions via topical
passive immunisation, which has also been suggested as a
treatment via transdermal delivery with microneedles [44]. Passive
neutralization of CAMP factor in infected lesions appears, as we
might expect, not to influence the colonization of the bacterium at
other body sites [44]; although it should be noted that these studies
were only performed in a mouse ear model of skin inflammation
and bacteria were only enumerated after an overnight incubation.
In the future, it will be important to determine exactly what effect,
if any, a possible CAMP-factor targeted vaccine would have on
‘commensal’ strains. This will be essential as no definite evidence
currently exists that CAMP factor 2 plays any significant or central
role in the pathophysiology of acne vulgaris.
Analysis of genome synteny between P. acnes, P.
humerusii and P. avidum
The high amino acid sequence identities between shared CAMP
factor homologues in the genomes of P. acnes, P. avidum and P.
humerusii prompted us to investigate the relationship among the
complete genome sequences using progressiveMauve, which is a
multiple genome alignment tool [69]. We found that P. acnes shows
a relatively high synteny with P. humerusii, differing by 30.7% in the
pairwise alignment (pairwise genome content distance) and with
only two inverted local collinear blocks (LCB) (Figure 6). In
contrast, P. avidum has lower synteny with both P. acnes and
P. humerusii, differing by 46.8% and 47.3%, respectively, and with
five inverted LCBs. These results therefore mirror the phyloge-
netic relationships between the species as based on 16S rDNA
analysis (Figure S5), and further illustrate the close evolutionary
relationship that exists between P. acnes and P. humerusii.
Conclusions
P. acnes has been an underestimated and underreported cause of
different human infections and maladies [70]. The demonstration
via phylogenetic and genetic population studies that particular
genetic divisions and lineages exist with a heightened ability to
cause disease, while others appear health associated, now provides
a solid platform for evidential-based, hypothesis-driven, research
into the exact role of this organism in human disease. Against this
background, molecular characterisation of isolates by MLST prior
to further analyses, such as antimicrobial susceptibility testing or
host-pathogen interactions, will now provide a valuable foundation
on which we can build our understanding of the relationship
between specific lineages and pathogenicity. This will be vitally
important as we seek to develop new and specific therapeutic and
diagnostic strategies for P. acnes-related diseases. MLST represents
an ideal approach for isolate characterisation due to the highly
portable nature of the methodology and the non-subjective
interpretation of the results, unlike gel-based typing systems [71].
The demonstration in this study that MLST analysis based on only
four loci, along with simple cross reference to allelic profiles
available in the P. acnes MLST database (http://pubmlst.org/
pacnes/), provides accurate phylogenetic data for researchers, but
with a significant reduction in costs, labour and time, should prove
beneficial for researchers within this context.
While acne is not a life threatening condition, it can have severe
psychological effects on sufferers. To date, the mainstay treatment
for this skin condition has been the administration of topical
retinoids and topical and oral antibiotics [72]. In recalcitrant cases
isotretinoin may be prescribed, but this drug can have severe side
effects. The development of a vaccine against acne has long been
sought after, and its possible effect on other P. acnes-related
diseases, particularly prostate cancer (if a causal link can be
proven), may prove an added bonus. Current discussions centred
on the use of P. acnes CAMP2 as a therapeutic target for acne are
interesting, and while in vitro and mouse ear models of infection
provide evidence of a potentially efficacious outcome upon
targeting of this protein, this must be balanced against the fact
that the role of CAMP2 in the pathophysiology of acne has not
been established. In addition, current animal models used to study
the potential role of this ‘virulence’ factor in acne are unrealistic in
relation to modelling the human skin environment. The demon-
stration herein that the camp2 gene appears to be evolving under
functional constraints similar to housekeeping genes and is present
and expressed in all strains, including those from genetic divisions
containing health-associated lineages, suggests it may also be
important for a commensal/normal existence as well as patho-
genic lifestyle. The observation that the camp2 gene may have been
purged from other propionibacteria where, we can presume, it was
not essential for adaptation, further supports a possible role in P.
acnes survival on the human host. Interestingly, the double life of
some bacterial housekeeping genes as virulence factors has been
described [73]. In our opinion, therefore, proposed CAMP factor-
related vaccines should be pursued with caution at this stage;
indeed it is essential to demonstrate that immunisation with any
target antigen does not disrupt commensal lineages within the skin
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microbiome that are associated with maintaining health via
modulation of the innate immune host response and prevention of
colonisation by more pathogenic microbes. As we describe in this
paper, the investigation of P. acnes clonal diversification, combined
with selection analysis and other in silico-based investigations, will
enable informed choices to be made in relation to the further
exploration of candidate vaccines.
Materials and Methods
Bacterial strains
All bacterial strains were maintained at 280uC in Brain Heart
Infusion broth (Oxoid), containing 12% (v/v) glycerol, prior to
analysis. P. acnes was cultured on Columbia agar base (Oxoid)
supplemented with 5% (v/v) bovine blood, hemin (1 mg ml21) and
vitamin K1 (5 mg ml21) for 72 h at 37uC in a vinyl anaerobic
chamber (Coy Laboratories), under an atmosphere of 10% H2,
10% CO2 and 80% N2. A total of 87 isolates from acneic lesions
(n = 24), healthy skin covering ‘acne-prone’ areas (n = 19), blood
(n = 15), soft tissue infections (n = 27) and medical devices (n = 2)
were analysed as part of this study (Table 2) [74].
MLST analysis
Partial sequences of the housekeeping gene loci atpD (453 bp),
gmk (400 bp), guaA (493 bp), lepA (452 bp), sodA (450 bp), tly
(777 bp) and camp2 (804 bp) were determined after PCR using
primer pairs and amplification conditions previously described [9].
For aroE, a new set of forward (59-ACCGATTAAGAGTGAC-
TACC-39) and reverse (59-ACTCCTCGGAAATCTCTACA-39)
MLST primers were designed that target flanking sequences of the
aroE open reading frame, and give rise to a 1102 bp amplicon
(424bp after sequencing). PCR conditions were essentially as
before, except that an annealing temperature of 56uC and MgCl2
concentration of 2.5 mM were used. PCR products were purified
on MiniElute UF plates (Qiagen) and sequenced as detailed
previously [9]. Novel alleles for each locus were assigned a new
allele number, and distinct allelic profiles a new ST number, using
the P. acnes MLST website (http://pubmlst.org/pacnes/). All
MLST gene sequences are freely available for download at this
site.
Data analysis
The number of polymorphic sites, the average synonymous/
non-synonymous site ration (dNdS), the nucleotide diversity per site
(p), the average number of nucleotide differences per site (h),
Tajima D test and sliding window analysis were determined using
DnaSp version 5 [75]. Mean pairwise distance (p-distance) and
phylogenetic analysis using the Minimum Evolution algorithm
were carried using MEGA v5.0. Split decomposition trees were
generated using SplitsTree version 4.1 [76]. Evidence for
recombination breakpoints was assessed using the genetic algo-
rithm detection (GARD) method [77] prior to analysis of
individual codons for positive or negative selection using FEL
(Fixed Effects Likelihood) and REL (Random Effects Likelihood)
methods with REV and HKY85 models of nucleotide substitution
[41]. Index of association values (IA) were determined following the
method of Haubold & Hudson [78] with LIAN v3.5 software.
Clonal groups were identified using the eBURST v3 clustering
algorithm which will also identify the most likely (i.e., parsimo-
nious) ancestral ST within each clonal complex (http://www.mlst.
net) [79]. Multiple amino acid alignments were created using
PRofile ALIgNEment (PRALINE) (http://www.ibi.vu.nl/
programs/pralinewww/) [80]. The presence of signal peptide
cleavage sites in amino acid sequences was determined using
SignalP v4.1 [81]. Simpson’s discriminatory index (D), 95%
confidence intervals (CI) and RAND values were determined as
previously described [82].
Multiple genome alignment
In order to investigate the rearrangement patterns and synteny
between P. acnes (6609, GenBank accession no. CP002815) [83],
P. avidum (ATCC25577, GenBank accession no. NZ_JH165060)
and P. humerusii (P08, GenBank accession no. NZ_A-
FAM00000000) [55] genomes, we performed multiple alignments
using the progressiveMauve algorithm (v2.3.1) [69]. We utilized
the genome content distance matrix output of Mauve to quantify
the differences in the aligned sequences.
Estimation of recombination verses mutation rates
The per-allele and per-site recombination/mutation (r/m) ratio
was estimated as previously described [84]. In brief, mutation events
were presumed if the variant allele differed from the descendent
SLV at one site, and this was not present in any other STs within the
collection. Recombination events were identified if the variant allele
differed at multiple sites or a single site which was also present in
other STs of the collection, and not the result of vertical descent as
clearly evident from inspection of an eBURST population diagram.
Statistics
Data distributions were compared using the Chi Squared test,
and statistical evidence of recombination using the phi test. P values
for the discriminatory significance of the MLST schemes were
calculated using the jack-knife pseudo-values re-sampling method.
Supporting Information
Figure S1 Alignment of aroE gene sequences represent-
ing all P. acnes phylogroups. Sequences corresponding to the
binding regions of the forward and reverse aroE amplification
primers previously described for MLST analysis [9] are shaded.
These primers were originally designed using whole genome data
from the type IB strain KPA171202 [25]. Mismatches within the
primer sequences are highlighted in red.
(PPT)
Figure S2 Minimum evolution phylogenetic trees of (A)
recA and (B) rpoB housekeeping genes from HMP taxa
incorrectly classified as novel Propionibacterium spe-
cies or P. acnes. Sequence input order was randomized, and
bootstrapping resampling statistics were performed using 500 data
sets. Bootstrap values (.50%) are shown on the arms of the tree.
Homologous sequences from P. humerusii (P08; HL037PA1;
HL044PA1) and P. avidum (ATCC25577) were used as outgroups.
Horizontal bar represents genetic distance. HMP isolates CC003-
HC2, 409-HCl, 434-HC2 and 5U42AFAA (highlighted in red),
identified as potentially novel taxa, clearly cluster with P. acnes.
HMP isolate SK182B-JCVI (highlighted in blue), classified as P.
acnes, forms a distinct lineage from P. acnes strains; this was most
pronounced with rpoB. Strains of P. acnes are represented by 266
(type IA1), P. acn33 (type IA2), KPA171202 (type IB), HL097PA1
(type IC), ATCC11828 (type II) and Asn12 (type III).
(PPT)
Figure S3 Split decomposition analysis of all individual
genes from the P. acnes MLST scheme. No evidence of
statistically significant recombination was identified in either the
housekeeping or putative virulence gene sequences; although for
loci such as aroE, guaA and sodA evidence of limited recombination
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events were identified due to the presence of interconnected
pathways. P values were determined using the phi test.
(PPT)
Figure S4 Amino acid alignments of CAMP factor
homologues from P. acnes, P. humerusii and P. avidum.
Multiple sequence alignments were created using PRofile
ALIgNEment (PRALINE) (http://www.ibi.vu.nl/programs/
pralinewww/). (A) CAMP1 alignment, P. acnes versus P. humerusii
(91% identity); (B) CAMP3 alignment, P. acnes versus P. humerusii
(98% identity); (C) CAMP5 alignment, P. acnes versus P. humerusii
(84% identity); (D) CAMP3 alignment, P. acnes versus P. avidum
(92–93%); (E) CAMP5 alignment, P. acnes versus P. avidum (80%
identity); (F) CAMP3 alignment, P. humerusii versus P. avidum (92–
93% identity); (G) CAMP5 alignment, P. humerusii versus P. avidum
(80% identity). P. acnes is represented by the type strain NCTC737
(type IA1; ST1; CC1); P. humerusii by P08, HL044PA1, HL037PA2
and HL037PA3; P. avidum by ATCC25577, 440671.
(TIF)
Figure S5 Minimum evolution phylogenetic tree of 16S
rDNA sequences for type strains of the genus Propioni-
bacterium. Sequence input order was randomized and boot-
strapping resampling statistics were performed using 500 data sets.
The 16S rDNA sequence from Nocardia asteroides was used as a
distant outgroup to root the tree as it also belongs to the order
Actinomycetales. Bootstrap values (.50%) are shown at each node of
the tree. The blocks of species which could be analysed for the
presence of CAMP factor homologues are highlighted. Horizontal
bar represents genetic distance. Note, in P humerusii, the camp4 gene
generates a truncated product compared to the equivalent
homologue in P. acnes.
(PPT)
Figure S6 CAMP factor homologues appear located in
similar regions within P. acnes, P. avidum and P.
humerusii genomes. Local collinear blocks are shown for P.
acnes (6609, type IB, ST5, CC5; top), P. avidum (ATCC25577;
middle) and P. humerusii (P08; bottom). Horizontally organised
open rectangles show annotation of P. acnes genome; vertical open
rectangles show the location of the given CAMP factor: (A) camp1
(B) camp2 (C) camp3 (D) camp4 (E) camp5.
(TIF)
Table S1 Evaluation of MLST4 with MLST8 for the
identification of phylogroup, CC and ST status of
isolates. By cross-referencing the four gene allelic profile to the
full allelic profiles currently available within the growing P. acnes
MLST database (http://pubmlst.org/pacnes/), it was possible to
accurately determine the phylogroup (IA1, IA2, IB, IC, II and III)
and CC/singleton identity. STs that could not be completely
differentiated by MLST4 (16/91) are colour coded. Even in these
cases, however, the MLST4 allelic profiles still correctly deter-
mined phylogroup and CC membership (S = singleton; CC = clo-
nal complex).
(DOC)
Table S2 MLST results for all 372 P. acnes isolates
analysed to date. A total of 114 STs were generated based on
the analysis of eight gene loci.
(DOC)
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